MXPA03005428A - Nuevas proteinas y moleculas de acido nucleico moduladoras del receptor de glutamato y uso de las mismas. - Google Patents
Nuevas proteinas y moleculas de acido nucleico moduladoras del receptor de glutamato y uso de las mismas.Info
- Publication number
- MXPA03005428A MXPA03005428A MXPA03005428A MXPA03005428A MXPA03005428A MX PA03005428 A MXPA03005428 A MX PA03005428A MX PA03005428 A MXPA03005428 A MX PA03005428A MX PA03005428 A MXPA03005428 A MX PA03005428A MX PA03005428 A MXPA03005428 A MX PA03005428A
- Authority
- MX
- Mexico
- Prior art keywords
- nucleic acid
- acid molecules
- glutamate receptor
- uses therefor
- receptor modulatory
- Prior art date
Links
- 102000018899 Glutamate Receptors Human genes 0.000 title 1
- 108010027915 Glutamate Receptors Proteins 0.000 title 1
- 102000039446 nucleic acids Human genes 0.000 title 1
- 108020004707 nucleic acids Proteins 0.000 title 1
- 150000007523 nucleic acids Chemical class 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
- G01N33/9406—Neurotransmitters
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/286—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against neuromediator receptors, e.g. serotonin receptor, dopamine receptor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Pharmacology & Pharmacy (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Neurosurgery (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Psychology (AREA)
- Wood Science & Technology (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25758900P | 2000-12-22 | 2000-12-22 | |
PCT/US2001/049817 WO2002070708A2 (en) | 2000-12-22 | 2001-12-21 | Glutamate receptor modulatory proteins and nucleic acids encoding them |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA03005428A true MXPA03005428A (es) | 2003-09-10 |
Family
ID=22976904
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA03005428A MXPA03005428A (es) | 2000-12-22 | 2001-12-21 | Nuevas proteinas y moleculas de acido nucleico moduladoras del receptor de glutamato y uso de las mismas. |
Country Status (10)
Country | Link |
---|---|
US (1) | US20020142330A1 (es) |
EP (1) | EP1390496A2 (es) |
JP (1) | JP2004537277A (es) |
KR (1) | KR20030074675A (es) |
CN (1) | CN1714151A (es) |
BR (1) | BR0116420A (es) |
CA (1) | CA2432280A1 (es) |
IL (1) | IL156519A0 (es) |
MX (1) | MXPA03005428A (es) |
WO (1) | WO2002070708A2 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2200606A1 (en) * | 1995-07-26 | 1997-02-13 | Nps Pharmaceuticals, Inc. | Chimeric receptors and methods for identifying compounds active at metabotropic glutamate receptors and the use of such compounds in the treatment of neurological disorders and diseases |
US20050186658A1 (en) * | 2003-10-17 | 2005-08-25 | Nps Pharmaceuticals, Inc. | Chimeric metabotropic glutamate receptors and uses thereof |
WO2005075989A1 (en) * | 2004-01-28 | 2005-08-18 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with human metabotropic glutamate receptor 5 (mglur5) |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5869609A (en) * | 1990-12-12 | 1999-02-09 | Zymogenetics, Inc. | G protein coupled glutamate receptors |
US5521297A (en) * | 1993-06-04 | 1996-05-28 | Salk Institute Biotechnology/Industrial Associates | Nucleic acids encoding human metabotropic glutamate receptors |
US6001581A (en) * | 1993-06-04 | 1999-12-14 | Sibia Neurosciences, Inc. | Cation-based bioassay using human metabotropic glutamate receptors |
US6211353B1 (en) * | 1994-07-29 | 2001-04-03 | Eli Lilly And Company | Isolated nucleic acid encoding a human mGluR5 |
CA2200606A1 (en) * | 1995-07-26 | 1997-02-13 | Nps Pharmaceuticals, Inc. | Chimeric receptors and methods for identifying compounds active at metabotropic glutamate receptors and the use of such compounds in the treatment of neurological disorders and diseases |
AU2486999A (en) * | 1998-01-30 | 1999-08-16 | University Technology Corporation | Polynucleotide and polypeptide sequences associated with cns depressant sensitivity and methods of use thereof |
AU5897500A (en) * | 1999-07-02 | 2001-01-22 | Neurocrine Biosciences, Inc. | Metabotropic glutamate receptors and methods of use therefor |
US6534287B1 (en) * | 1999-10-25 | 2003-03-18 | Nps Pharmaceuticals, Inc. | Human metabotropic glutamate receptor |
US20020142952A1 (en) * | 2000-04-06 | 2002-10-03 | Wong Gordon G. | Polynucleotides encoding novel secreted proteins |
-
2001
- 2001-12-21 CN CNA018228062A patent/CN1714151A/zh active Pending
- 2001-12-21 WO PCT/US2001/049817 patent/WO2002070708A2/en not_active Application Discontinuation
- 2001-12-21 MX MXPA03005428A patent/MXPA03005428A/es unknown
- 2001-12-21 CA CA002432280A patent/CA2432280A1/en not_active Abandoned
- 2001-12-21 JP JP2002570733A patent/JP2004537277A/ja active Pending
- 2001-12-21 IL IL15651901A patent/IL156519A0/xx unknown
- 2001-12-21 EP EP01272486A patent/EP1390496A2/en not_active Withdrawn
- 2001-12-21 KR KR10-2003-7008495A patent/KR20030074675A/ko not_active Application Discontinuation
- 2001-12-21 US US10/027,923 patent/US20020142330A1/en not_active Abandoned
- 2001-12-21 BR BRPI0116420-1A patent/BR0116420A/pt not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
BR0116420A (pt) | 2006-02-21 |
IL156519A0 (en) | 2004-01-04 |
EP1390496A2 (en) | 2004-02-25 |
CN1714151A (zh) | 2005-12-28 |
JP2004537277A (ja) | 2004-12-16 |
CA2432280A1 (en) | 2002-09-12 |
KR20030074675A (ko) | 2003-09-19 |
US20020142330A1 (en) | 2002-10-03 |
WO2002070708A3 (en) | 2003-12-04 |
WO2002070708A2 (en) | 2002-09-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001241412A1 (en) | Nucleic acids, proteins, and antibodies | |
AU2001249929A1 (en) | Fdrg proteins and nucleic acid molecules and uses therefor | |
MXPA03005428A (es) | Nuevas proteinas y moleculas de acido nucleico moduladoras del receptor de glutamato y uso de las mismas. | |
AU2002231194A1 (en) | G protein-coupled receptor protein and nucleic acid molecules and uses therefor | |
AU2001290872A1 (en) | Isolated human kinase proteins, nucleic acid molecules and uses thereof | |
AU2001229508A1 (en) | Nucleic acids, proteins, and antibodies | |
AU2001273077A1 (en) | Slgp protein and nucleic acid molecules and uses therefor | |
AU2001283092A1 (en) | Novel ebi-3-alt protein and nucleic acid molecules and uses therefor | |
AU2001236461A1 (en) | Nucleic acids, proteins, and antibodies | |
AU2001239726A1 (en) | Nucleic acids, proteins, and antibodies | |
AU2001230958A1 (en) | Nucleic acids, proteins, and antibodies | |
AU2001239728A1 (en) | Nucleic acids, proteins, and antibodies | |
AU2001241403A1 (en) | Nucleic acids, proteins, and antibodies | |
AU2001237948A1 (en) | Nucleic acids, proteins, and antibodies | |
AU2001237946A1 (en) | Nucleic acids, proteins, and antibodies | |
AU2001241411A1 (en) | Nucleic acids, proteins, and antibodies | |
AU2001236460A1 (en) | Nucleic acids, proteins, and antibodies | |
AU2001236459A1 (en) | Nucleic acids, proteins, and antibodies | |
AU2001237953A1 (en) | Nucleic acids, proteins, and antibodies | |
AU2001241419A1 (en) | Nucleic acids, proteins, and antibodies |